Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits.

Nguyen, Christine P; Hirsch, Mark; Kaul, Suresh; Woods, Corinne; Joffe, Hylton V.

Afiliação

Nguyen CP; Division of Urology, Obstetrics and Gynecology, Office of New Drugs, Pediatrics, Urologic and Reproductive Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Hirsch M; Division of Urology, Obstetrics and Gynecology, Office of New Drugs, Pediatrics, Urologic and Reproductive Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Kaul S; Division of Urology, Obstetrics and Gynecology, Office of New Drugs, Pediatrics, Urologic and Reproductive Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Woods C; Division of Epidemiology II, Office of Surveillance and Epidemiology, Pediatrics, Urologic and Reproductive Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Joffe HV; Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Androg Clin Res Ther ; 2(1): 56-60, 2021.

Article em En | MEDLINE | ID: mdl-34041509